CHEMOTHERAPY OF MAINTENANCE IN BREAST CANCER WITHOUT HORMONE RESPONSE

Not Applicable

• Conditions: -C50 Malignant neoplasm of breast; Malignant neoplasm of breast; C50

• Registration Number: PER-077-03
• Lead Sponsor: INTERNATIONAL BREAST CANCER STUDY GROUP - IBCSG,

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2004-01-22
• Last Update Posted: 20 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

Premenopausal or postmenopausal patients with histologically proven primary breast cancer.
Estrogen and progesterone receptor status must be known by immunohistochemistry, before randomization, and both must be negative, which is defined as < 10% of the tumor cells positive by immunohistochemical evaluation.

Exclusion Criteria

Patients with T4 carcinoma with ulceration of skin, infiltration of skin.
Patients with bilateral malignancies (except in situ carcinoma), or with a suspicious mass in the opposite breast, tmless that mass has been proven by biopsy to be benign.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<br>Outcome name:not contemplated<br>Measure:not contemplated<br>Timepoints:not contemplated<br>

Secondary Outcome Measures

Name	Time	Method
<br>Outcome name:not contemplated<br>Measure:not contemplated<br>Timepoints:not contemplated<br>